BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10089294)

  • 1. Pharmacodynamics of insulin in polyethylene glycol-coated liposomes.
    Kim A; Yun MO; Oh YK; Ahn WS; Kim CK
    Int J Pharm; 1999 Mar; 180(1):75-81. PubMed ID: 10089294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encapsulation enhancement and stabilization of insulin in cationic liposomes.
    Park SJ; Choi SG; Davaa E; Park JS
    Int J Pharm; 2011 Aug; 415(1-2):267-72. PubMed ID: 21645598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged blood circulation of methotrexate by modulation of liposomal composition.
    Hong MS; Lim SJ; Lee MK; Kim YB; Kim CK
    Drug Deliv; 2001; 8(4):231-7. PubMed ID: 11757781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the insulin-liposomes double-coated by chitosan and chitosan-EDTA conjugates].
    Wu ZH; Ping QN; Song YM; Lei XM; Li JY; Cai P
    Yao Xue Xue Bao; 2004 Nov; 39(11):933-8. PubMed ID: 15696937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of surface-coated liposomes for oral delivery of peptide: effects of coating the liposome's surface on the GI transit of insulin.
    Iwanaga K; Ono S; Narioka K; Kakemi M; Morimoto K; Yamashita S; Namba Y; Oku N
    J Pharm Sci; 1999 Feb; 88(2):248-52. PubMed ID: 9950646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical-chemistry characteristics and biodistribution of poly(ethylene glycol)-coated liposomes using poly(oxyethylene) cholesteryl ether.
    Ishiwata H; Vertut-Doï A; Hirose T; Miyajima K
    Chem Pharm Bull (Tokyo); 1995 Jun; 43(6):1005-11. PubMed ID: 7641302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of PEG-containing liposomal formulations on in vivo pharmacokinetics of streptokinase.
    Jin SE; Kim IS; Kim CK
    Arch Pharm Res; 2015 Oct; 38(10):1822-9. PubMed ID: 25851624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin.
    Yu F; Li Y; Liu CS; Chen Q; Wang GH; Guo W; Wu XE; Li DH; Wu WD; Chen XD
    Int J Pharm; 2015 Apr; 484(1-2):181-91. PubMed ID: 25724135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery.
    Sheshala R; Peh KK; Darwis Y
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1364-74. PubMed ID: 19832637
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Mutlu-Agardan NB; Han S
    Pharm Dev Technol; 2021 Feb; 26(2):157-166. PubMed ID: 33183103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes.
    Takeuchi H; Yamamoto H; Niwa T; Hino T; Kawashima Y
    Pharm Res; 1996 Jun; 13(6):896-901. PubMed ID: 8792429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled release of insulin from pH/temperature-sensitive injectable pentablock copolymer hydrogel.
    Huynh DP; Im GJ; Chae SY; Lee KC; Lee DS
    J Control Release; 2009 Jul; 137(1):20-4. PubMed ID: 19285530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral delivery of insulin via polyethylene imine-based nanoparticles for colonic release allows glycemic control in diabetic rats.
    Salvioni L; Fiandra L; Del Curto MD; Mazzucchelli S; Allevi R; Truffi M; Sorrentino L; Santini B; Cerea M; Palugan L; Corsi F; Colombo M
    Pharmacol Res; 2016 Aug; 110():122-130. PubMed ID: 27181095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel PLGA-based nanoparticles for the oral delivery of insulin.
    Malathi S; Nandhakumar P; Pandiyan V; Webster TJ; Balasubramanian S
    Int J Nanomedicine; 2015; 10():2207-18. PubMed ID: 25848248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioadhesive Chitosan-Coated Cationic Nanoliposomes With Improved Insulin Encapsulation and Prolonged Oral Hypoglycemic Effect in Diabetic Mice.
    Shalaby TI; El-Refaie WM
    J Pharm Sci; 2018 Aug; 107(8):2136-2143. PubMed ID: 29689252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary delivery of insulin by liposomal carriers.
    Huang YY; Wang CH
    J Control Release; 2006 Jun; 113(1):9-14. PubMed ID: 16730838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery.
    Kumar A; Lahiri SS; Singh H
    Int J Pharm; 2006 Oct; 323(1-2):117-24. PubMed ID: 16828246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice.
    Wu ZH; Ping QN; Wei Y; Lai JM
    Acta Pharmacol Sin; 2004 Jul; 25(7):966-72. PubMed ID: 15210073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor.
    Li H; Song JH; Park JS; Han K
    Int J Pharm; 2003 Jun; 258(1-2):11-9. PubMed ID: 12753749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin.
    Jain S; Rathi VV; Jain AK; Das M; Godugu C
    Nanomedicine (Lond); 2012 Sep; 7(9):1311-37. PubMed ID: 22583576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.